This is an observational study for people with non-small cell lung cancer (NSCLC) that has spread (metastatic) or is locally advanced. The study is looking at how well standard treatments recommended by the National Comprehensive Cancer Network (NCCN) work in patients receiving them as a second or third treatment. We want to understand the "Objective Response Rate" (ORR), which means how many patients see their cancer shrink or disappear after treatment. You might be able to join if you are over 18, have NSCLC, have a good performance status (meaning you can do most daily activities), and are expected to live more than 3 months. The study aims to gather information to create a comparison group for future research.

Study design

This is an observational study, meaning participants will be observed while receiving standard care. The study plans to include about 650 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint will be assessed between September 2025 and April 2029.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.